MACC1 and neoplasm: Since its discovery, numerous studies in a variety of different solid cancer entities such as CRC, gastric and hepatocellular carcinoma, demonstrated that MACC1 serves as a prognostic biomarker for patient tumor progression and metastasis [5, 6, 9–12].